MedicaidPrior AuthMedium impact
KMAP BULLETIN: Preferred Drug List Update
Kansas Medicaid (KanCare)·KS · Endocrinology, Family Medicine, General Practice +2 more·Pharmacy
Effective date
Apr 1, 2024
We identified it
Jun 21, 2026
Summary
Kansas Medicaid (KMAP) updated their Preferred Drug List effective April 1, 2024, requiring prior authorization for Saxenda, Wegovy, generic tetracycline tablets, and generic indomethacin oral suspension. Zepbound is now preferred and does not require prior authorization.
Action Required
Effective April 1, 2024: Billing team must update prior authorization requirements for Kansas Medicaid patients receiving Saxenda (Liraglutide), Wegovy (Semaglutide), generic tetracycline tablets, or generic indomethacin oral suspension. Update EMR alerts to notify providers that these medications require PDL prior authorization. Monitor KanCare MCO implementation status on the KMAP Bulletins page as implementation dates may vary by MCO.